Walter Slowinski, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 126 Main St, Putney, VT 05346 Phone: 802-387-5581 Fax: 802-387-6694 |
Thomas Hoskins, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 7 Small Meadows Ln, Putney, VT 05346 Phone: 802-387-5917 |
Emily Forbes-mobus, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 79 Main St, Putney, VT 05346 Phone: 802-257-0341 |
Dr. Kari Lynn Dickey, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 79 Main St., Putney, VT 05346 Phone: 802-387-5581 Fax: 802-387-6694 |
News Archive
TriposĀ®, a leading provider of drug discovery informatics products and services, today announced the release and general availability of SYBYL-X Version 1.1. This new release focuses on enhancing research productivity for scientists in the pharmaceutical, agrochemical, flavors and fragrances, and related industries, featuring faster navigation, new menus and toolbars, and new ways to approach life science molecular discovery projects. Previous SYBYL versions have been the benchmark for the industry in molecular modeling, and customers using this new, next generation version have given it high marks.
A 200-patient Phase 2 clinical pilot study will be initiated this month to test the efficacy and safety of a new use, and method of administering, an enzyme inhibitor for critically ill patients developed by University of California, San Diego Bioengineering Professor Geert Schmid-Sch-nbein. Conditions expected to qualify for the study include new-onset sepsis and septic shock, post-operative complications, and new-onset gastrointestinal bleeding.
ADHD, or attention-deficit/hyperactivity disorder, is among the costliest of behavioral disorders. Its combination of inattention, impulsivity and hyperactivity leads to accidental injuries, school failure, substance abuse, antisocial behavior and more. Yet despite nearly a century of study, the disorder's roots remain mysterious.
Scientists reveal the structure of one of the most important and complicated proteins in cell division - a fundamental process in life and the development of cancer - in research published in Nature today (Sunday).
Mayo Clinic researchers have found a novel way to monitor real-time chemical changes in the brains of patients undergoing deep brain stimulation (DBS). The groundbreaking insight will help physicians more effectively use DBS to treat brain disorders such as Parkinson's disease, depression and Tourette syndrome.
› Verified 1 days ago